Contribution of neuronal nitric oxide (NO) synthase to N-acetylcysteine- induced increase of no synthase activity in the brain of normotensive and hypertensive rats

Journal of Physiology and Pharmacology

Volumn 60, Issue 4, 2009, Pages 21-25

  Pechanova, O ^b,c   Kunes, J ^a,b   Dobesova, Z ^a,b   Vrankova, S ^c   Zicha, Josefa ^a,b  

^a Center for Cardiovascular Research   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Brainstem; Cerebellum; N acetylcysteine; Neuronal NOS; S methyl L thiocitrulline; Spontaneous hypertension

Indexed keywords

ACETYLCYSTEINE; ARGININE; CITRULLINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; S METHYL LEVO THIOCITRULLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; HEART WEIGHT; HYPERTENSION; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE;

ACETYLCYSTEINE; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; BRAIN; BRAIN STEM; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; HEART; HYPERTENSION; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; ORGAN SIZE; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SPECIES SPECIFICITY;

EID: 75749111689     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Head R.J. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 1989; 26: 1-20.
2. De Champlain J. Pre- and postsynaptic adrenergic dysfunctions in hypertension. J Hypertens 1990 ; 8(Suppl 7): S77-S85.
3. Luscher TF. Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension? Am J Hypertens 1990; 3: 317-330.
4. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44: 245-252.
5. Kojsova S, Jendekova L, Zicha J, Kunes J, Andriantsitohaina R, Pechanova O. The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol Res 2006; 55 (Suppl 1): S3-S16.
6. Pechanova O, Zicha J, Kojsova S, Dobesova Z, Jendekova L, Kunes J. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin Sci 2006; 110: 235-242.
7. Pechanova O, Zicha J, Paulis L, et al. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol 2007; 561: 129-136.
8. ω-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species. Hypertens Res 2005; 28: 472-485.
9. Zicha J, Dobesova Z, Kunes J. Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertens Res 2006; 29: 1021-1027.
10. Krukoff TL. Central regulation of autonomic function: NO brakes? Clin Exp Pharmacol Physiol 1998; 25: 474-478.
11. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003; 139: 191-202.
12. Dampney RA, Horiuchi J, Killinger S, Sheriff MJ, Tan PS, McDowall LM. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol 2005; 32: 419-425.
13. Cabrera CL, Bealer SL, Bohr DF. Central depressor action of nitric oxide is deficient in genetic hypertension. Am J Hypertens 1996; 9: 237-241.
14. Kagiyama S, Tsuchihashi I, Abe I, Fujishima M. Enhanced depressor response to nitric oxide in the rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertension 1998; 31: 1030-1034.
15. Qadri F, Arens T, Schwarz E-C, Hauser W, Dendorfer A, Dominiak P. Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension. J Hypertens 2003; 21: 1687-694.
16. Hauser W, Sassmann A, Qadri F, Johren O, Dominiak P. Expression of nitric oxide synthase isoforms in hypothalamo-pituitary-adrenal axis during the development of spontaneous hypertension in rats. Brain Res Mol Brain Res 2005; 138: 198-204.
17. Hojna S, Kadlecova M, Dobesova Z, Valouskova V, Zicha J, Kunes J. The participation of brain NO synthase in blood pressure control of adult spontaneously hypertensive rats. Mol Cell Biochem 2007; 297: 21-29.
18. Plochocka-Zulinska D, Krukoff TL. Increased gene expression of neuronal nitric oxide synthase in brain of adult spontaneously hypertensive rats. Brain Res Mol Brain Res 1997; 48: 291-297.
19. Edwards MA, Loxley RA, Powers-Martin K, et al. Unique levels of expression of N-methyl-D-aspartate receptor subunits and neuronal nitric oxide synthase in the rostral ventrolateral medulla of the spontaneously hypertensive rat. Brain Res Mol Brain Res 2004; 129: 33-43.
20. Furfine ES, Harmon MF, Paith JE, et al. Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J Biol Chem 1994; 269: 26677-26683.
21. Wakefield ID, March JE, Kemp PA, Valentin JP, Bennett T, Gardiner SM. Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats. Br J Pharmacol 2003; 139: 1235-1243.
22. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682-685.
23. Pechanova O, Bernatova I. Effect of captopril on cyclic nucleotide concentration during long-term NO synthase inhibition. Physiol Res 2000; 49: 55-63.
24. Gadek-Michalska A, Bugajski J. Nitric oxide in the adrenergic- and CRH-induced activation of hypothalamo-pituitary-adrenal axis. J Physiol Pharmacol 2008; 59: 365-378.
25. Martina V, Masha A, Gigliardi VR, et al. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 2008; 31: 940-944.
26. Cabassi A, Dumont EC, Girouard H, et al. Effect of chronic N-acetylcysteine treatment on the actions of peroxynitrate on aortic vascular reactivity in hypertensive rats. J Hypertens 2001; 19: 1233-1244.
27. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosterone-induced inflammation in the rat heart : role of oxidative stress. Am J Pathol 2002; 161: 1773-1781.
28. Lahera V, Khraibi AA, Romero JC. Sulfhydryl group donors potentiate the hypotensive effect of acetylcholine in rats. Hypertension 1993; 30: 934-941.
29. Brozmanova M, Plevka J, Bartos V, et al. Oral N-acetylcysteine reverses hyperoxia-induced cough suppression in guinea pigs. J Physiol Pharmacol 2008; 58(Suppl 5): 75-84.
30. Arakawa M, Ito Y. N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology. Cerebellum 2007; 19: 1-7.
31. Jayalakshmi K, Sairam M, Singh SB, Sharma SK, Ilavazhagan G, Banerjee PK. Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture. Brain Res 2005; 1046: 97-104.
32. Sury MD, Frese-Schaper M, Muhlemann MK, et al. Evidence that N-acetylcysteine inhibits TNF-alpha-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase. Free Radic Biol Med 2006; 41: 1372-1383.
33. Macarthur H, Westfall TC, Wilken GH. Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats. Am J Physiol 2008; 294: H183-H189.
34. Osborn JW. Hypothesis: set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney. Clin Exp Pharmacol Physiol 2005; 32: 384-393.
35. Bergamaschi CT, Campos RR, Lopes OU. Rostral ventrolateral medulla: a source of sympathetic activation in rats subjected to long-term treatment with L-NAME. Hypertension 1999; 34: 744-747.
36. Tsuchihashi T, Kagiyama S, Matsumura K, Lin Y, Abe I, Fujishima M. Cardiovascular responses to glutamate and angiotensin II in ventrolateral medulla of hypertension induced by chronic inhibition of nitric oxide. Hypertens Res 2000; 23: 359-364.
37. Bergamaschi CT, Biancardi VC, Lopes OU, Campos RR. Effects of angiotensin blockade in the rostral ventrolateral medulla on maintenance of hypertension induced by chronic L-NAME treatment. Brain Res 2002; 927: 195-199.
38. Girouard H, Chulak C, Wu L, LeJossec M, de Champlain J. N-Acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats. Am J Hypertens 2003; 16: 577-584.
39. Kunes J, Dobesova Z, Zicha J. Chronic N-acetylcysteine treatment prevents the development of salt hypertension in immature Dahl rat. J Hypertens 2004; 22(Suppl 2): S336.
40. Kristek F, Koprdova R, Cebova M. Long-term effects of early administered sildenafil and NO donor on the cardiovascular system of SHR. J Physiol Pharmacol 2007; 58: 33-43.
41. Bernatova I, Csizmadiova Z, Kopincova J, Puszerova A. Vascular function and nitric oxide production in chronic social-stress-exposed rats with various family history of hypertension. J Physiol Pharmacol 2007; 58: 487-501.